Cannabis Stock Movers For April 19, 2024

GAINERS: Global Compliance (OTC:FUAPF) shares closed up 72.62% at $0.01 Affinor Growers (OTC:RSSFF) shares closed up 26.96% at…

GAINERS:

  • Global Compliance (OTC:FUAPF) shares closed up 72.62% at $0.01
  • Affinor Growers (OTC:RSSFF) shares closed up 26.96% at $0.06
  • Body and Mind (OTC:BMMJ) shares closed up 21.02% at $0.08
  • CNBX Pharmaceuticals (OTC:CNBX) shares closed up 9.62% at $0.01
  • Elixinol Wellness (OTC:ELLXF) shares closed up 8.57% at $0.00
  • CV Sciences (OTC:CVSI) shares closed up 8.09% at $0.04
  • Corbus Pharmaceuticals (NASDAQ:CRBP) shares closed up 7.42% at $39.24
  • iAnthus Capital Hldgs (OTC:ITHUF) shares closed up 7.10% at $0.02
  • Charlottes Web Holdings (OTC:CWBHF) shares closed up 4.22% at $0.22
  • Argent Biopharma (OTC:MGCLF) shares closed up 3.85% at $0.27

LOSERS:

  • 1933 Industries (OTC:TGIFF) shares closed down 26.67% at $0.01
  • Blueberries Medical (OTC:BBRRF) shares closed down 10.95% at $0.01
  • Nextleaf Solutions (OTC:OILFF) shares closed down 8.98% at $0.09
  • 4Front Ventures (OTC:FFNTF) shares closed down 8.89% at $0.09
  • 22nd Century Group (NASDAQ:XXII) shares closed down 8.19% at $1.62
  • RIV Capital (OTC:CNPOF) shares closed down 7.92% at $0.07
  • Belgravia Hartford Cap (OTC:BLGVF) shares closed down 7.19% at $0.01
  • C21 Investments (OTC:CXXIF) shares closed down 6.59% at $0.31
  • Trulieve Cannabis (OTC:TCNNF) shares closed down 5.95% at $10.74
  • Genetic Technologies (NASDAQ:GENE) shares closed down 4.92% at $2.32
  • Cresco Labs (OTC:CRLBF) shares closed down 4.76% at $2.00
  • Green Thumb Industries (OTC:GTBIF) shares closed down 4.33% at $12.37
  • Greenlane Hldgs (NASDAQ:GNLN) shares closed down 3.04% at $0.63

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Craft Cannabis Co. Grown Rogue Sees 29% Revenue Increase In Q4, Expands Construction Progress In New Jersey

Grown Rogue International has reported a 29% YoY increase in revenue for its fiscal Q4 2023, reaching $6.5m. The cannabis company saw a 3% sequential increase in revenue, despite a downturn in its Oregon outdoor business. The firm's CEO, Obie Strickler, said that despite sales being down from the previous quarter, Grown Rogue is on an "upward trajectory." Other Q4 financial highlights include gross profit of $4.4m and an adjusted EBITDA of $2.1m, compared to an adjusted EBITDA gain of $1.7m in the prior year's period. Grown Rogue unveiled plans to enter New Jersey's cannabis market, with construction already underway and scheduled to be completed in Q2 2024.

CSE:GDNS